Expression of proteins controlling transbilayer movement of plasma membrane phospholipids in the B lymphocytes from a patient with Scott syndrome

Blood

Volumn 92, Issue 5, 1998, Pages 1707-1712

  Zhou, Quansheng ^a   Sims, Peter J ^a   Wiedmer, Therese ^a  

^a BLOOD RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BILAYER MEMBRANE; BLEEDING DISORDER; CONTROLLED STUDY; HUMAN; HUMAN CELL; LIPID TRANSPORT; MEMBRANE TRANSPORT; PRIORITY JOURNAL; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0032170973     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v92.5.1707     Document Type: Article

References (37)

1. Schroit AJ, Zwaal RFA: Transbilayer movement of phospholipids in red cell and platelet membranes. Biochim Biophys Acta 1071:313, 1991
2. Devaux P: Static and dynamic lipid asymmetry in cell membranes. Biochemistry 30:1163, 1991
3. Dolis D, Moreau C, Zachowski A, Devaux PF: Aminophospholipid translocase and proteins involved in transmernbrane phospholipid traffic. Biophys Chem 68:221, 1997
4. Tang XJ, Halleck MS, Schlegel RA, Williamson P: A subfamily of P-type ATPases with aminophospholipid transporting activity. Science 272:1495, 1996
5. Zwaal RFA, Schroit AJ: Pathophysiologic implications of membrane phospholipid asymmetry in blood cells. Blood 89:1121, 1997
6. 2+ induces transbilayer redistribution of all major phospholipids in human erythrocytes. Biochemistry 31:6355, 1992
7. Chang C-P, Zhao J, Wiedmer T, Sims PJ: Contribution of platelet microparticle formation and granule secretion to the transmembrane migration of phosphatidylserine. J Biol Chem 268:7171, 1993
8. Smeets EF, Comfurius P, Bevers EM, Zwaal RFA: Calcium-induced transbilayer scrambling of fluorescent phospholipid analogs in platelets and erythrocytes. Biochim Biophys Acta Bio-Membr 1195: 281, 1994
9. Bevers EM, Comfurius P, Zwaal RF: Platelet procoagulant activity: Physiological significance and mechanisms of exposure. Blood Rev 5:146, 1991
10. Sims PJ, Faioni EM, Wiedmer T, Shattil SJ: Complement proteins C5b-9 cause release of membrane vesicles from the platelet surface that are enriched in the membrane receptor for coagulation factor Va and express prothrombinase activity. J Biol Chem 263:18205, 1988
11. Wang RH, Phillips G Jr, Medof ME, Mold C: Activation of the alternative complement pathway by exposure of phosphatidylethanolamine and phosphatidylserine on erythrocytes from sickle cell disease patients. J Clin Invest 92: 1326, 1993
12. Fadok VA, Voelker DR, Campbell PA, Cohen JJ, Bratton DL, Henson PM: Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages. J Immunol 148:2207, 1992
13. 2+-dependent transbilayer movement of phospholipid. J Biol Chem 271:17205, 1996
14. 2+-dependent transbilayer migration of membrane phospholipids. J Clin Invest 99:2232, 1997
15. Zhou Q, Zhao J, Stout JG, Luhm RA, Wiedmer T, Sims PJ: Molecular cloning of human plasma membrane phospholipid scramblase - A protein mediating transbilayer movement of plasma membrane phospholipids. J Biol Chem 272:18240, 1997
16. 2+-accelerated transbilayer movement of membrane phospholipids. Biochemistry 37:2356, 1998
17. Zhao J, Zhou Q, Wiedmer T, Sims PJ: Level of expression of phospholipid scramblase regulates induced movement of phosphatidyl-serine to the cell surface. J Biol Chem 273:6603, 1998
18. Weiss HJ, Vicic WJ, Lages BA, Rogers J: Isolated deficiency of platelet procoagulant activity. Am J Med 67:206, 1979
19. Weiss HJ: Scott Syndrome: A disorder of platelet coagulant activity (PCA). Semin Hematol 31:312, 1994
20. Sims PJ, Wiedmer T, Esmon CT, Weiss HJ, Shattil SJ: Assembly of the platelet prothrombinase complex is linked to vesiculation of the platelet plasma membrane. Studies in Scott syndrome: An isolated defect in platelet procoagulant activity. J Biol Chem 264:17049, 1989
21. a binding sites on the platelets of a patient with a bleeding disorder. Blood 54:1015, 1979
22. Ahmad SS, Rawala-Sheikh R, Ashby B, Walsh PN: Platelet receptor-mediated factor X activation by factor IXa: High-affinity factor IXa receptors induced by factor VIII are deficient on platelets in Scott syndrome. J Clin Invest 84:824, 1989
23. Toti F, Satta N, Fressinaud E, Meyer D, Freyssinet J-M: Scott syndrome, characterized by impaired transmembrane migration of procoagulant phosphatidylserine and hemorrhagic complications, is an inherited disorder. Blood 87:1409, 1996
24. 2+-induced loss of phospholipid asymmetry in the human erythrocyte. A study in Scott Syndrome, a disorder of calcium-induced phospholipid scrambling. Blood 86:1983, 1995
25. 2+-induced microvesiculation and deficient expression of procoagulant activity in erythrocytes from a patient with a bleeding disorder: A study of the red blood cells of Scott syndrome. Blood 79:380, 1992
26. Kojima H, Newton-Nash D, Weiss HJ, Zhao J, Sims PJ, Wiedmer DT: Production and characterization of transformed B-lymphocytes expressing the membrane defect of Scott syndrome. J Clin Invest 94:2237, 1994
27. Dachary-Prigent J, Pasquet JM, Fressinaud E, Toti F, Freyssinet JM, Nurden AT: Aminophospholipid exposure, microvesiculation and abnormal protein tyrosine phosphorylation in the platelets of a patient with Scott syndrome: A study using physiologic agonists and local anaesthetics. Br J Haematol 99:959, 1997
28. 2+-induced tyrosine phosphorylation and defective lipid scrambling in erythrocytes from a patient with Scott syndrome: A study using an inhibitor for scramblase that mimics the defect in Scott syndrome. Blood 91:2133, 1998
29. Toti F, Schindler V, Riou JF, Lombard-Platet G, Fressinaud E, Meyer D, Uzan A, Le Pecq JB, Mandel JL, Freyssinet JM: Another-link between phospholipid transmembrane migration and ABC transporter gene family, inferred from a rare inherited disorder of phosphatidylserine externalization. Biochem Biophys Res Commun 241:548, 1997
30. Gottesman MM, Pastan I: Biochemistry of multidrug resistance mediated by the mulridrug transporter. Annu Rev Biochem 62:385, 1993
31. Elferink RPJO, Tytgat GNJ, Groen AK: The role of mdr2 P-glycoprotein in hepatobiliary lipid transport. FASEB J 11:19, 1997
32. Crawford AR, Smith AJ, Hatch VC Elferink RPJO, Borst P, Crawford JM: Hepatic secretion of phospholipid vesicles in the mouse critically depends on mdr2 or MDR3 P-glycoprotein expression Visualization by electron microscopy. J Clin Invest 100:2562, 1997
33. Bosch I, Dunussi-Joannopoulos K, Wu RL, Furlong ST, Croop J: Phosphatidylcholine and phosphatidylethanolamine behave as substrates of the human MDR1 P-glycoprotein. Biochemistry 36:5685, 1997
34. Van Helvoort A, Smith AJ, Sprong H, Fritzsche I, Schinkel AH, Borst P, van Meer G: MDR1 P-glycoprotein is a lipid translocase of broad specificity, while MDR3 P-glycoprotein specifically translocates Phosphatidylcholine. Cell 87:507, 1996
35. Pilarski LM, Paine D, McElhaney JE, Cass CE, Belch AR: Multirug transporter P-glycoprotein 170 as a differentiation antigen on normal human lymphocytes and thymocytes: Modulation with differentiation stage and during aging. Am J Hematol 49:323, 1995
36. Grulois I, Fardel O, Drenou B, Lamy T, Le Prise PY, Fauchet R: Multidrug resistance in B-cell chronic lymphocytic leukemia. Acta Haematol 94:78, 1995
37. 2+-activated transbilayer movement of membrane phospholipids. Biochemistry 37:6361, 1998